EV/EBITDA
N/A
23 min ago
Summary
- RDHL EV/EBITDA is not available.
Performance
RDHL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RDHL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | +6.0% | +0.5% |
| 1 m1 month | - | -58.1% | -11.3% |
| 3 m3 months | - | -81.0% | -28.2% |
| 6 m6 months | - | -93.9% | -58.6% |
| ytdytd | - | -48.4% | -8.0% |
| 1 y1 year | - | -94.0% | -57.5% |
| 5 y5 years | - | -99.5% | -99.9% |
RDHL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | 0.12 | 0.07 | ||
| 3 y | 3-year | 0.24 | -5.72 | ||
| 5 y | 5-year | 0.24 | -17.93 | ||
| alltime | all time | 1.77 | -24.04 |
RedHill Biopharma EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | 0.21(-104.0%) |
| 2022 | -5.22(+70.0%) |
| 2021 | -3.07(-54.1%) |
| 2020 | -6.69(+40.5%) |
| 2019 | -4.76(+42.9%) |
| Date | Value |
|---|---|
| 2018 | -3.33(+56.3%) |
| 2017 | -2.13(-49.0%) |
| 2016 | -4.18(-38.3%) |
| 2015 | -6.77(-39.9%) |
| 2014 | -11.27(+90.4%) |
| 2013 | -5.92 |
FAQ
- What is the all time high EV/EBITDA for RedHill Biopharma?
What is the all time high EV/EBITDA for RedHill Biopharma?
RedHill Biopharma all-time high EV/EBITDA is 1.77